Development of anti-centromere antibody-positive autoimmune hepatitis after childbirth

Clin J Gastroenterol. 2020 Oct;13(5):855-859. doi: 10.1007/s12328-020-01092-w. Epub 2020 Jan 20.

Abstract

This is the first case involving the development of anti-centromere antibody (ACA)-positive autoimmune hepatitis (AIH) after childbirth that triggered nailfold bleeding. A 32-year-old woman visited a dermatologist presenting with nailfold bleeding 6 months after the delivery of her second baby. Blood tests revealed liver dysfunction, and she was admitted to our hospital. Tests for hepatitis virus, antinuclear antibody, and anti-mitochondrial antibody were negative. She had no history of alcohol consumption or oral medication. Because of nailfold bleeding, we performed tests for ACA, anti-Scl-70 antibody, anti-RNA polymerase III antibody, and anti-U1 RNP antibodies; only ACA was positive. A liver biopsy was performed for the diagnosis of liver dysfunction. Histological examination of the liver biopsy specimen showed moderate infiltration of inflammatory cells, interface hepatitis, bridging fibrosis, and bile duct injury. The AIH international score was 17, and thus, we diagnosed AIH. Oral prednisolone (PSL) 0.6 mg/day/body weight was initiated. Two weeks post-treatment, the liver enzyme levels normalized and the nailfold bleeding disappeared. In case of nailfold bleeding complicated with liver dysfunction post-childbirth, ACA-positive AIH should be considered as a differential diagnosis.

Keywords: Anti-centromere antibody; Autoimmune hepatitis; Nailfold bleeding.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Antinuclear
  • Bile Duct Diseases*
  • Biopsy
  • Female
  • Hepatitis, Autoimmune* / diagnosis
  • Hepatitis, Autoimmune* / drug therapy
  • Humans
  • Prednisolone / therapeutic use
  • Pregnancy

Substances

  • Antibodies, Antinuclear
  • Prednisolone